BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11743840)

  • 1. When is it cost-effective to change the behavior of health professionals?
    Mason J; Freemantle N; Nazareth I; Eccles M; Haines A; Drummond M
    JAMA; 2001 Dec; 286(23):2988-92. PubMed ID: 11743840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The costs of making practice more cost-effective.
    Weeks WB; Wallace AE
    JAMA; 2002 Apr; 287(13):1648; author reply 1649-50. PubMed ID: 11926883
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication prescribing advice and drug utilization: a review from the United Kingdom.
    Law J; Thompson A
    Pharm Pract Manag Q; 1996 Jan; 15(4):27-35. PubMed ID: 10153842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
    Siegel D; Lopez J; Meier J
    Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
    [No Abstract]   [Full Text] [Related]  

  • 6. Leveraging drug-utilization and external benchmarking data to drive change in prescribing behaviors.
    O'Neal BC; Couldry RJ; Wilkinson ST; Cannella CA; Williams CB; Scott LA; Simpson SQ
    Am J Health Syst Pharm; 2012 Nov; 69(21):1916-22. PubMed ID: 23111677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing the cost and value of medications: the dilemma facing clinicians.
    Avorn J
    Pharmacoeconomics; 2002; 20 Suppl 3():67-72. PubMed ID: 12457426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
    Prosser H; Walley T
    Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What a physician needs to know about cost-effectiveness.
    Heidenreich PA; Lee TT
    Cardiol Rev; 2000; 8(2):96-102. PubMed ID: 11174880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of educational outreach ('academic detailing') to improve clinical decision making.
    Soumerai SB; Avorn J
    JAMA; 1990 Jan; 263(4):549-56. PubMed ID: 2104640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing community dyspepsia drug costs: a controlled trial.
    Valori RM; Brown CM; Strangeways P; Bradburn M
    Gut; 2001 Oct; 49(4):495-501. PubMed ID: 11559645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economics in epilepsy treatment choices: our certain fate?
    Heaney DC; Beran RG; Halpern MT
    Epilepsia; 2002; 43 Suppl 4():32-8. PubMed ID: 12059999
    [No Abstract]   [Full Text] [Related]  

  • 13. Physician awareness of drug cost: a systematic review.
    Allan GM; Lexchin J; Wiebe N
    PLoS Med; 2007 Sep; 4(9):e283. PubMed ID: 17896856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational prescribing in primary care (RaPP): economic evaluation of an intervention to improve professional practice.
    Fretheim A; Aaserud M; Oxman AD
    PLoS Med; 2006 Jun; 3(6):e216. PubMed ID: 16737349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferred drug lists: potential impact on healthcare economics.
    Ovsag K; Hydery S; Mousa SA
    Vasc Health Risk Manag; 2008; 4(2):403-13. PubMed ID: 18561515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998.
    Nelson MR; McNeil JJ; Peeters A; Reid CM; Krum H
    Med J Aust; 2001 Jun; 174(11):565-8. PubMed ID: 11453328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the Cost-Effectiveness of Implementation: Is Sufficient Evidence Available?
    Whyte S; Dixon S; Faria R; Walker S; Palmer S; Sculpher M; Radford S
    Value Health; 2016; 19(2):138-44. PubMed ID: 27021746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rising prescription drug costs: whose responsibility?
    Hill SR; Henry DD; Smith AJ
    Med J Aust; 1997 Jul; 167(1):6-7. PubMed ID: 9236749
    [No Abstract]   [Full Text] [Related]  

  • 19. What a physician needs to know about cost-effectiveness: commentary.
    Cheitlin MD
    Cardiol Rev; 2000; 8(2):103. PubMed ID: 11174881
    [No Abstract]   [Full Text] [Related]  

  • 20. Can physicians practice cost-effective medicine?
    Conti CR
    Clin Cardiol; 1998 Jan; 21(1):2-3. PubMed ID: 9474458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.